Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study

ABSTRACT: The Prediction of Anastomotic Insufficiency risk after Colorectal surgery (PANIC) study aims to establish a machine-learning-based application that allows for accurate preoperative prediction of patients at risk for anastomotic insufficiency after colon and colorectal surgery.

DISEASE(S): Mesenteric Ischemia,Ulcerative Colitis,Colorectal Cancer,Diverticulosis,Diverticulum,Crohn Disease,Anastomotic Leak,Diverticular Diseases

PROVIDER: 2385155 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Machine learning-based prediction of the activity and specificity of Cas9 variants in gene editing

Project description:Machine learning-based prediction of the activity and specificity of Cas9 variants in gene editing

2024-08-22 | GSE231840 | GEO

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

Project description:The primary objectives of this study are: * To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG * To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG

| 2373934 | ecrin-mdr-crc

Prediction of Breast Cancer Estrogen Receptor Status using Machine Learning

Project description:Gene expression profiles were generated from 199 primary breast cancer patients. Samples 1-176 were used in another study, GEO Series GSE22820, and form the training data set in this study. Sample numbers 200-222 form a validation set. This data is used to model a machine learning classifier for Estrogen Receptor Status. RNA was isolated from 199 primary breast cancer patients. A machine learning classifier was built to predict ER status using only three gene features.

2013-01-01 | E-GEOD-29210 | biostudies-arrayexpress

GNHS proteome SWATH data datatat

Project description:Here, we explored the feasibility to use a protein-based machine learning model for risk prediction of MetS in a prospective cohort.

2023-03-11 | PXD039236 |

DNA Methylation Biomarkers for Cervical Cancer Risk Prediction in HIV-Positive Nigerian Women

Project description:Cervical cancer (CC) remains a significant public health issue in low- and middle-income countries (LMICs), especially in Western sub-Saharan Africa and Nigeria. While global CC incidence and mortality have declined, these regions continue to face high rates due to inadequate screening and the high prevalence of HIV, which increases CC risk by promoting persistent HPV infections. This study aimed to identify DNA methylation (DNAm) biomarkers for cervical intraepithelial neoplasia (CIN) and CC in HIV-positive Nigerian women and to assess their potential for clinical risk prediction. From 2018 to 2020, 538 participants were recruited from Nigerian tertiary hospitals. Cervical tissue samples were analyzed for DNAm using the Infinium MethylationEPIC BeadChip array, and HPV genotyping was conducted via next-generation sequencing. An epigenome-wide association study revealed 24 significant DNAm biomarkers associated with CIN and CC. These biomarkers showed hypermethylation in tumor suppressor genes (e.g., PRMD8), hypomethylation in oncogenes (e.g., MIR520H), and aberrant methylation in genes related to HIV/HPV infection and oncogenesis (e.g., GNB5, LMO4, FOXK2, NMT1). A machine learning-based DNAm classifier achieved 92.9% sensitivity and 88.6% specificity in predicting CC risk, with higher risk observed in adjacent normal cervical samples from CIN/CC patients and HIV/HPV co-infected women. DNAm biomarkers offer a promising approach to enhancing CC screening and early detection, particularly for HIV-positive women in LMICs. The DNAm-based model developed in this study shows potential for more accurate CC risk stratification, highlighting the need for further optimization, validation, and implementation in low-resource settings.

2024-11-01 | GSE279982 | GEO

AI Prediction Model and Risk Stratification for Lung Metastasis in Colorectal Cancer

Project description:Background: To assist clinicians with diagnosis and optimal treatment decision-making, we attempted to develop and validate an artificial intelligence prediction model for lung metastasis (LM) in colorectal cancer (CRC) patients. Method: The clinicopathological characteristics of 46037 CRC patients from the Surveillance, Epidemiology, and End Results (SEER) database and 2779 CRC patients from a multi-center external validation set were collected retrospectively. After feature selection by univariate and multivariate analyses, six machine learning (ML) models, including logistic regression, K-nearest neighbor, support vector machine, decision tree, random forest, and balanced random forest (BRF), were developed and validated for the LM prediction. The optimization model with best performance was compared to the clinical predictor. In addition, stratified LM patients by risk score were utilized for survival analysis.

| 46649 | ecrin-mdr-crc

High-throughput proteomic analysis of rectal cancer for prediction of non-complete response after concurrent chemoradiation therapy

Project description:Colorectal cancer (CRC) is the third most common lethal malignancy in Korea and worldwide. Rectal cancer patients occupy about 30% of CRC patients, and the majority of rectal cancer patients had locally advanced disease at diagnosis. The standard treatment of locally advanced rectal cancer (LARC) is neoadjuvant radiation therapy with concurrent chemotherapy (CCRT) followed by total mesorectal excision (TME). This multidisciplinary team approach improved local tumor control and overall survival of rectal cancer patients. High throughput proteomic analysis and machine learning algorithm identify DUOX2 (dual oxidase 2) as a novel biomarker for prediction of non-complete response after concurrent chemoradiation therapy for rectal cancer.High throughput proteomic analysis and machine learning algorithm identify DUOX2 (dual oxidase 2) as a novel biomarker for prediction of non-complete response after concurrent chemoradiation therapy for rectal cancer.

2023-03-11 | PXD023302 | Pride

Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data

Project description:We perform a large-scale RNA sequencing study to experimentally identify genes that are downregulated by 25 miRNAs. This RNA-seq dataset is combined with public miRNA target binding data to systematically identify miRNA targeting features that are characteristic of both miRNA binding and target downregulation. By integrating these common features in a machine learning framework, we develop and validate an improved computational model for genome-wide miRNA target prediction. All prediction data can be accessed at miRDB (http://mirdb.org).

2019-01-11 | GSE124530 | GEO

HuiyiLi2024 - Prediction of death risk in patients with acute diquat poisoning using Random Forest Model

Project description:The objective of this study was to develop and validate predictive models to assess the risk of death in patients with acute diquat (DQ) poisoning using innovative machine learning techniques. The study analyzed data from 201 consecutive patients admitted for deliberate oral intake of DQ between February 2018 and August 2023 at the First Hospital and Shengjing Hospital of China Medical University. Initial clinical data were collected, and four machine learning methods—logistic regression, random forest, support vector machine (SVM), and gradient boosting—were applied to build the prediction models. The dataset was split into a training set and a test set in an 8:2 ratio. The performance of these models was evaluated in terms of discrimination, calibration, and clinical decision curve analysis (DCA). Additionally, the SHapley Additive ExPlanations (SHAP) interpretation tool was used to provide an intuitive explanation of the risk of death in patients with DQ poisoning by calculating the contribution and impact of each feature on the final prediction. The areas under the receiver operating characteristic curves (AUCs) for the models were 0.91 for logistic regression, 0.98 for random forest, 0.96 for SVM, and 0.94 for gradient boosting. The random forest model demonstrated the best predictive performance with the highest AUC of 0.98, highest F1-score (0.90), highest Matthews correlation coefficient (0.79), highest accuracy (0.90), and the lowest Brier score (0.07). The study concludes that these machine learning models, combined with SHAP, provide reliable and interpretable tools for predicting the death risk in patients with acute DQ poisoning, with the random forest model being identified as the best performing model.

2024-07-18 | MODEL2407180001 | BioModels

Cell-free DNA 5-hydroxymethylcytosine for immunotherapy response prediction in lung cancer

Project description:Immune checkpoint inhibitors (ICIs) drastically improve therapeutic outcomes for lung cancer, but accurate prediction of individual patient responses to ICIs remains a challenge. We performed a genome-wide analysis of 5-hydroxymethylcytosine (5hmC) in plasma cell-free DNA (cfDNA) samples from 83 lung cancer patients. Using machine learning approaches, we developed a 5hmC signature to predict ICI treatment response and calculated a weighted-predictive score (wp-score) based on the 5hmC levels of signature genes in each sample. A low wp-score was significantly correlated with longer progression-free survival across three independent patient sample sets, and demonstrated superior predictive capability to tumor programmed death-ligand 1. Moreover, we identified novel 5hmC-associated genes and signaling pathways integral to ICI treatment response in lung cancer. Our study suggests that cfDNA 5hmC analysis is a minimally invasive, innovative strategy for guiding treatment selection in lung cancer patients.

2024-02-28 | GSE237087 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data